Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - dapoxetine hydrochloride 33.6mg equivalent to dapoxetine 30 mg;   - film coated tablet - 30 mg - active: dapoxetine hydrochloride 33.6mg equivalent to dapoxetine 30 mg   excipient: colloidal silicon dioxide croscarmellose sodium coating powder grey 4 lactose monohydrate as a spray-dried mixture of lactose monohydrate & microcrystalline cellulose magnesium stearate microcrystalline cellulose as a spray-dried mixture of lactose monohydrate & microcrystalline cellulose - priligy is indicated for the treatment of premature ejaculation (pe) in men 18 to 64 years of age, who have all of the following: · persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the patient wishes; and · marked personal distress or interpersonal difficulty as a consequence of pe; and · poor control over ejaculation.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - dapoxetine hydrochloride 67.2mg equivalent to dapoxetine 60 mg;   - film coated tablet - 60 mg - active: dapoxetine hydrochloride 67.2mg equivalent to dapoxetine 60 mg   excipient: colloidal silicon dioxide croscarmellose sodium coating powder grey 3 lactose monohydrate as a spray-ried mixture of lactose monohydrate & microcrystalline cellulose magnesium stearate microcrystalline cellulose as a spray-ried mixture of lactose monohydrate & microcrystalline cellulose - priligy is indicated for the treatment of premature ejaculation (pe) in men 18 to 64 years of age, who have all of the following: · persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the patient wishes; and · marked personal distress or interpersonal difficulty as a consequence of pe; and · poor control over ejaculation.

Irland - Englisch - HPRA (Health Products Regulatory Authority)

a. menarini pharmaceuticals ireland ltd - dapoxetine - film-coated tablet - 30 milligram(s) - other urologicals; dapoxetine

Irland - Englisch - HPRA (Health Products Regulatory Authority)

a. menarini pharmaceuticals ireland ltd - dapoxetine - film-coated tablet - 60 milligram(s) - other urologicals; dapoxetine

Malta - Englisch - Medicines Authority

a. menarini pharmaceuticals ireland limited castlecourt, monkstown farm, monkstown, glenageary, co dublin, ireland - dapoxetine - film-coated tablet - dapoxetine 30 mg - urologicals

Malta - Englisch - Medicines Authority

a. menarini pharmaceuticals ireland limited castlecourt, monkstown farm, monkstown, glenageary, co dublin, ireland - dapoxetine - film-coated tablet - dapoxetine 60 mg - urologicals

Europäische Union - Englisch - EMA (European Medicines Agency)

bayer ag - riociguat - hypertension, pulmonary - antihypertensives for pulmonary arterial hypertension - chronic thromboembolic pulmonary hypertension (cteph) adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah) adempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. efficacy has been shown in a pah population including aetiologies of idiopathic or heritable pah or pah associated with connective tissue disease.

Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

amgrow pty ltd - bifenthrin - suspension concentrate - bifenthrin pyrethroid active 100.0 g/l - insecticide

Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

adama australia pty limited - trifloxystrobin; tebuconazole - suspension concentrate - trifloxystrobin strobiluron active 10.0 g/l; tebuconazole triazole active 200.0 g/l - fungicide

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - dapoxetine hydrochloride, quantity: 33.6 mg (equivalent: dapoxetine, qty 30 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; titanium dioxide; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; iron oxide yellow; microcrystalline cellulose; hypromellose; triacetin; iron oxide black - priligy is indicated for the treatment of premature ejaculation (pe) in men 18 to 64 years of age, who have all of the following: an intravaginal ejaculatory latency time (ielt) of less than two minutes; and persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the patient wishes; and marked personal distress or interpersonal difficulty as a consequence of pe; and poor control over ejaculation.